La tétracycline, connue sous le nom commercial Sumycin, agit en bloquant la fixation de l’ARNt sur la sous-unité 30S ribosomale, interrompant l’élongation de la chaîne protéique bactérienne. Ce mécanisme confère une activité sur un spectre large, incluant bactéries Gram positives, Gram négatives, rickettsies et spirochètes. Sa biodisponibilité digestive varie selon la prise alimentaire et les interactions avec les ions divalents comme calcium et magnésium. Sa diffusion tissulaire est importante, notamment dans les voies respiratoires et génito-urinaires. L’élimination se fait par voie rénale et biliaire. Les effets indésirables incluent photosensibilisation, troubles digestifs et coloration dentaire en cas d’administration précoce. Les guides thérapeutiques mentionnent sumycin prix, en soulignant la nécessité de restreindre son utilisation afin de limiter les résistances acquises.
Wcup moscow 2008_w_fin.pdf
SC "Olympiyskiy" 30 May 2008 Start time 11:00 Competition 3 Final at the apparatus Rank Dress Name Country "Ⱥ" Total AD ND 208 BARBOSA Jade 5.80 9.10 9.10 9.40 9.00 9.30 9.30 9.200 5.60 9.00 9.00 8.90 8.90 8.80 8.80 8.900 242 PAVLOVA Anna 5.80 9.20 9.00 9.20 9.20 9.30 9.30 9.225 5.60 8.80 8.60 8.90 8.90 8.90 9.00 8.875 246 KAESLIN Ariella 6.30 9.20 8.80 9.30 8.70 8.90 9.00 8.975 5.00 8.80 9.00 8.70 9.00 8.80 9.00 8.900 214 DENG Linlin 5.80 9.10 8.90 9.10 9.00 9.00 9.20 9.050 5.00 9.00 9.20 9.20 8.80 9.00 8.70 9.000 211 MARACHKOVSKAYA Nastassia 5.50 9.30 9.10 9.20 9.30 9.30 9.40 9.275 5.00 9.00 8.90 9.00 9.10 9.10 8.70 9.000 205 JOURA Daria 5.80 9.10 9.20 9.00 9.00 9.10 9.10 9.075 5.00 8.80 8.90 9.00 8.80 9.00 8.70 8.875 241 AFANASYEVA Ksenia 5.80 8.80 8.90 9.20 9.20 9.20 9.30 9.125 4.80 8.00 7.70 7.80 8.20 8.40 8.20 8.050 209 SOUZA Lais 5.50 8.70 8.80 9.10 9.00 8.90 9.00 8.925 4.80 7.90 8.00 7.80 8.10 8.10 8.00 8.000 Legend: AD - Average deduction, ND - Neutral deduction Results Software by ENGIS www.engis.ru Printed:30/05/08 15:29 SC "Olympiyskiy" 30 May 2008 Start time 11:00 Competition 3 Final at the apparatus Uneven bars Rank Dress Name Country "Ⱥ" score deduction 240 SEMENOVA Ksenia 7.20 9.20 8.90 9.00 8.60 8.60 9.00 215 PANG Panpan 7.10 8.00 8.80 8.60 8.20 8.40 8.00 249 ZGOBA Dariya 6.80 8.90 9.00 8.40 8.60 8.30 8.60 235 WONG Lichelle 6.70 8.00 8.30 8.30 8.40 8.30 8.20 206 MITCHELL Lauren 6.50 8.40 8.20 8.30 8.10 8.20 7.90 213 SUI Lu 5.90 8.60 8.60 8.10 8.40 8.70 8.50 231 PIHAN Marta 6.10 8.10 8.00 8.20 8.30 8.10 8.20 212 VACULIK Kristina 6.30 7.70 7.60 7.50 7.80 7.90 7.80 Results Software by ENGIS www.engis.ru Printed:30/05/08 15:30 SC "Olympiyskiy" 30 May 2008 Start time 11:00 Competition 3 Final at the apparatus Rank Dress Name Country "Ⱥ" score deduction 214 DENG Linlin 7.10 8.70 8.80 8.60 8.90 8.80 8.60 213 SUI Lu 6.70 8.80 8.40 8.80 8.50 8.70 8.90 242 PAVLOVA Anna 6.50 8.90 8.80 8.80 9.20 8.90 8.70 240 SEMENOVA Ksenia 6.40 8.50 8.80 8.70 8.50 8.90 8.90 206 MITCHELL Lauren 6.70 7.50 7.70 7.80 8.00 7.80 7.90 231 PIHAN Marta 6.30 8.00 8.20 8.00 8.00 7.40 8.20 208 BARBOSA Jade 6.10 7.50 7.60 7.60 7.50 7.20 7.60 235 WONG Lichelle 6.20 6.70 7.20 6.80 6.80 7.40 7.10 Results Software by ENGIS www.engis.ru Printed:30/05/08 15:31 SC "Olympiyskiy" 30 May 2008 Start time 11:00 Competition 3 Final at the apparatus Rank Dress Name Country "Ⱥ" score deduction 214 DENG Linlin 6.10 8.70 8.50 8.50 8.80 9.00 8.80 241 AFANASYEVA Ksenia 5.90 8.90 9.00 8.70 8.80 8.90 8.90 205 JOURA Daria 6.10 8.00 8.30 8.10 8.10 8.30 8.40 212 VACULIK Kristina 5.80 8.40 8.40 8.30 8.60 8.50 8.60 210 SILVA Ana Claudia 5.90 8.50 8.20 8.30 8.10 8.60 8.40 247 ZIMMERMANN Yasmin 5.80 8.50 8.10 8.30 8.30 8.40 8.30 231 PIHAN Marta 5.50 8.50 8.50 8.20 8.20 8.40 8.40 208 BARBOSA Jade 5.90 8.00 7.70 7.50 7.60 7.80 7.80 Results Software by ENGIS www.engis.ru Printed:30/05/08 15:32
Daniel M. Anthony Daniel Anthony's practice entails working with clients to define and execute effectivestrategies for establishing the highest level of protection possible for their intellectualproperty and technology rights. With a primary focus in litigation, Mr. Anthony also hassignificant experience with trade-m
Antares Pharma and Population Council Announce Phase I Results First Transdermal Contraceptive Gel Contains Nestorone® EWING, NJ, November 28, 2007, Antares Pharma, Inc. (AMEX: AIS) and the Population Council (an international, non-profit research organization) announced positive results from the Phase I trial for a novel contraceptive gel containing the progestin, Nestorone and
SC "Olympiyskiy"
SC "Olympiyskiy"
SC "Olympiyskiy"
SC "Olympiyskiy"